BioSpace News Archive

Biotech Bay

Nkarta to Present at Upcoming Investor Conference

Nkarta, Inc. today announced its participation at this upcoming investor conference:

June 16, 2021
·
1 min read
Business

Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board

Affimed N.V. today announced the appointment of Ms. Uta Kemmerich-Keil as director on its Supervisory Board effective immediately.

June 16, 2021
·
3 min read
Business

Dewpoint Appoints Michael Wagner, Ph.D., as Senior Vice President of Chemistry and Drug Discovery

Dewpoint Therapeutics today announced the appointment of Michael Wagner, Ph.D., as Senior Vice President of Chemistry and Drug Discovery.

June 16, 2021
·
2 min read
Business

InSphero and Pharmaceutical Companies Form Pre-Competitive Consortium to Advance Development of In Vitro Tools to Screen and Predict Drug-Induced Liver Injury (DILI)

InSphero AG today officially launched a pre-competitive consortium that brings together representatives from pharmaceutical companies engaged and invested in the development of cross-species drug testing.

June 16, 2021
·
4 min read
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004

Cybin Inc.today announced that it has selected social anxiety disorder (“SAD”) and generalized anxiety disorder (“GAD”) as the initial target indications for its proprietary psychedelic molecule CYB004.

June 16, 2021
·
8 min read
Deals

Acorda Therapeutics Announces Repayment of Convertible Senior Notes

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that on June 15, 2021, it repaid in full its 1.75% Convertible Senior Notes due 2021.

June 16, 2021
·
4 min read
Business

MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology

MacroGenics (NASDAQ: MGNX), and Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), announced today that the companies have entered into an exclusive collaboration and license agreement involving up to four immuno-oncology molecules.

June 16, 2021
·
8 min read
Business

KemPharm Issues Letter to Shareholders

KemPharm, Inc.today announced that Travis C. Mickle, Ph.D., President and CEO of KemPharm, has issued a Letter to Shareholders in connection with the Company’s 2021 Annual Meeting of Stockholders to be held on June 17, 2021.

June 16, 2021
·
10 min read
Drug Development

Servier Announces Promising Phase 1 Data for Vorasidenib in IDH Mutant Low-Grade Glioma Published in Clinical Cancer Research

- Servier today announced that Clinical Cancer Research has published data from its Phase 1 study evaluating single-agent vorasidenib in isocitrate dehydrogenase (IDH) mutant advanced solid tumors, including low-grade glioma.

June 16, 2021
·
8 min read
Biotech Bay

Accuray Expands CyberKnife® System Versatility with Integration of RaySearch’s RayStation Treatment Planning System

Accuray Incorporated announced the launch of RayStation* treatment planning support for the company’s CyberKnife® M6™** and S7™** Robotic, Radiotherapy Systems.

June 16, 2021
·
6 min read